The increasing incidence of cancer is one of the biggest factors responsible for the growing demand for molecular cytogenetics methods. This is because various molecular cytogenetics methods are heavily adopted for cancer diagnostic purposes. Besides this, the surging number of cancer research projects being conducted in several countries is also fueling the demand for molecular cytogenetics, on account of the fact that advanced methods are required for gaining a better understanding of the disease at the chromosomal level.
The growing popularity of genetic-based prediction and estimation of various chromosomal abnormalities, the surging population of geriatric people and their susceptibility to chronic ailments, and the rising usage of molecular cytogenetics in crop improvement are the other important factors adding wings to the molecular cytogenetics demand across the globe. This is, in turn, fueling the boom of the global molecular cytogenetics market. The market is predicted to progress at a CAGR of 9.9% from 2018 to 2023.
Furthermore, according to the forecast of P&S Intelligence, a market research company based in India, the value of the market would grow from $1.8 billion to $3.3 billion from 2017 to 2023. Based on technology, molecular cytogenetics is divided into karyotyping, immunohistochemistry (IHC), fluorescence in-situ hybridization (FISH), and comparative genomic hybridization (CGH). Amongst these, the demand for the FISH technology is expected to rise enormously over the next few years.
Thus, it is safe to say that the demand for molecular cytogenetics would skyrocket around the world in the forthcoming years, mainly because of the growing incidence of cancer and rapid technological advancements and innovations in medical research and disease diagnosis and prognosis processes.
